Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide

Gul, A; Garcia, JA; Barata, PC

Barata, PC (reprint author), Tulane Med Sch, Dept Internal Med, Sect Hematol & Med Oncol, 1430 Tulane Ave, New Orleans, LA 70112 USA.

CANCER MANAGEMENT AND RESEARCH, 2019; 11 (): 7253

Abstract

Androgen deprivation therapy (ADT) is an important component of systemic therapy in advanced prostate cancer; however, resistance to ADT is inevitable......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索